# LS Polaris Innovation Fund

> LS Polaris Innovation Fund is a VC fund backing Biotechnology, Medical and Biopharma. See 6 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Total investments: 6
- Last investment: Mar 2022
- Lead investor: 67%
- Last updated: Aug 2026
- Website: http://www.polarispartners.com/ls-polaris-innovation-fund/

LS Polaris Innovation Fund is a VC fund focused on Biotechnology and Medical. The LS Polaris Innovation Fund aims to accelerate the commercial and therapeutic potential of early stage academic research.

## Round sizes

| Stage | Round size |
| --- | --- |
| Series A | $22M–$82M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Biotechnology | 4 | 67% |
| Medical | 2 | 33% |
| Biopharma | 2 | 33% |
| Health Care | 2 | 33% |
| Life Science | 1 | 17% |

9 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 4 | 67% |
| Series B | 1 | 17% |
| Funding Round | 1 | 17% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| United States | 3 | 50% |
| Denmark | 1 | 17% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Satellite Bio | Satellite Bio specializes in cell therapy, regenerative medicine, synthetic biology, cell biology, and tissue engineering. It focuses on the development and implementation of proprietary, off-the-shelf, implantable satellite organs as living therapeutic solutions that can transform the lives of millions of patients who suffer from serious diseases. | $82.5M |  | Mar 07, 2022 |  |
| Satellite Bio | Satellite Bio specializes in cell therapy, regenerative medicine, synthetic biology, cell biology, and tissue engineering. It focuses on the development and implementation of proprietary, off-the-shelf, implantable satellite organs as living therapeutic solutions that can transform the lives of millions of patients who suffer from serious diseases. | $82.5M | Series A | Mar 07, 2022 |  |
| Muna Therapeutics | Muna Therapeutics discovers and develops therapies that slow or stop neurodegenerative diseases such as alzheimer’s and parkinson's. | $73M | Series A | Jul 09, 2021 |  |
| Glympse Bio | Glympse Bio is developing a powerful new paradigm in diagnostics to enable noninvasive and predictive monitoring of multiple human diseases. The company’s technology uses precisely engineered diagnostic agents that interrogate the body for certain disease states, and then carry the message to the urine for analysis. Glympse Bio’s platformtechnology was originally developed at MIT, and is founded by a team of world-renowned experts in nanomedicine and biomedical engineering. | $46.7M | Series B | Jul 15, 2020 |  |
| QurAlis | QurAlis is a operator of a biotechnology company intended to discover and develop potential precision therapeutics for amyotrophic lateral sclerosis (ALS). The company focuses on the link between genetics and disease in ALS and other neurological diseases, enabling doctors to successfully treat ALS . | $42M | Series A | May 13, 2020 |  |
| Glympse Bio | Glympse Bio is developing a powerful new paradigm in diagnostics to enable noninvasive and predictive monitoring of multiple human diseases. The company’s technology uses precisely engineered diagnostic agents that interrogate the body for certain disease states, and then carry the message to the urine for analysis. Glympse Bio’s platformtechnology was originally developed at MIT, and is founded by a team of world-renowned experts in nanomedicine and biomedical engineering. | $22M | Series A | Oct 09, 2018 |  |

6 of 6 investments shown.

## Co-investors
- [Polaris Partners](https://shizune.co/investors/profile/polaris-partners) — VC Fund, 4 deals together
- [aMoon Fund](https://shizune.co/investors/profile/amoon) — VC Fund, 3 deals together
- [Catalio Capital Management](https://shizune.co/investors/profile/catalio-capital-management) — VC Fund, 3 deals together
- [S32](https://shizune.co/investors/profile/section-32) — VC Fund, 3 deals together
- [CRV](https://shizune.co/investors/profile/crvvc) — VC Fund, 2 deals together
- [Droia Ventures](https://shizune.co/investors/profile/droia) — VC Fund, 2 deals together

## Similar investors

### Similar industry
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [Qiming Venture Partners](https://shizune.co/investors/profile/qiming-venture-partners) — VC Fund
- [Bpifrance](https://shizune.co/investors/profile/bpifrance) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

### Similar country
- [Vaekstfonden](https://shizune.co/investors/profile/v%C3%A6kstfonden) — VC Fund
- [PSV](https://shizune.co/investors/profile/preseed-innovation) — VC Fund
- [Seed Capital](https://shizune.co/investors/profile/seed-capital) — VC Fund

## Featured in investor lists
- [Medical VC Funds in Denmark](https://shizune.co/investors/medical-vc-funds-denmark)

## FAQ

### What does LS Polaris Innovation Fund invest in?

LS Polaris Innovation Fund invests primarily in Biotechnology, Medical and Biopharma startups, most often at Series A and Series B stage. Most of the 6 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is LS Polaris Innovation Fund's check size?

LS Polaris Innovation Fund typically joins rounds of $22M–$82M at Series A. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds LS Polaris Innovation Fund participates in.

### When did LS Polaris Innovation Fund last invest?

The most recent investment recorded for LS Polaris Innovation Fund closed in Mar 2022. Shizune tracks 6 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co